COPD patient satisfaction with ipratropium bromide/albuterol delivered via respimat: A randomized, controlled study

International Journal of COPD

Volumn 8, Issue , 2013, Pages 139-150

  Ferguson, Gary T ^a   Ghafouri, Mo ^b   Dai, Luyan ^b   Dunn, Leonard J ^c  

^a Pulmonary Research Institute of Southeast Michigan   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^c Clinical Research of West Florida Inc   (United States)

Author keywords

Consumer preference; Consumer satisfaction; COPD; Inhalers

Indexed keywords

IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL; SALBUTAMOL;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BACKACHE; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; COUGHING; DEVICE SAFETY; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG SAFETY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GASTROINTESTINAL DISEASE; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; MUSCULOSKELETAL CHEST PAIN; MUSCULOSKELETAL DISEASE; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SINUSITIS; THORAX PAIN; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT REFUSAL; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VOMITING;

CONSUMER PREFERENCE; CONSUMER SATISFACTION; COPD; INHALERS;

ADULT; AGED; AIRWAY MANAGEMENT; ALBUTEROL; BRONCHODILATOR AGENTS; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; DRUG MONITORING; DRUG THERAPY, COMBINATION; EQUIPMENT SAFETY; FEMALE; HUMANS; IPRATROPIUM; MALE; METERED DOSE INHALERS; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PATIENT PREFERENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84875286905     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S38577     Document Type: Article

References (12)

1. Global Initiative for Chronic Obstructive Lung Diseases. Global strategy for the diagnosis, management, and prevention of COPD [webpage on the Internet]; 2011 [updated Dec 2011]. Available from: http://www.goldcopd.org. Accessed October 1, 2012.
2. Fink JB, Hodder R. Adherence and inhaler devices in COPD. Respir Ther. 2011;6(1):28-33.
3. Vincken W, Dekhuijzen PR, Barnes P; for ADMIT Group. The ADMIT series - Issues in inhalation therapy. How to choose inhaler devices for the treatment of COPD. Prim Care Respir J. 2010;19(1):10-20.
4. Wieshammer S, Dreyhaupt J. Dry powder inhalers in asthma and COPD: which factors determine the frequency of handling errors? A study of Aerosolizer, Discus, Handihaler and Turbuhaler. Chest. 2007; 132(Suppl 4):479s.
5. van Beerendonk I, Mesters I, Mudde AN, Tan TD. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma. 1998;35(3):273-279.
6. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax. 2008; 63(9):831-838.
7. Epstein SW, Manning CP, Ashley MJ, Corey PN. Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J. 1979; 120(7):813-816.
8. Hartert TV, Windom HH, Peebles S, Freidhoff LR, Togias A. Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals. Am J Med. 1996;100(4):386-394.
9. Self TH, Arnold LB, Czosnowski LM, Swanson JM, Swanson H. Inadequate skill of healthcare professionals in using asthma inhalation devices. J Asthma. 2007;44(8):593-598.
10. Zuwallack R, De Salvo MC, Kaelin T, et al; for Combivent Respimat Inhaler Study Group. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. Respir Med. 2010; 104(8):1179-1188.
11. Kozma CM, Slaton TL, Monz BU, Hodder R, Reese PR. Development and validation of a patient satisfaction and preference questionnaire for inhalation devices. Treat Respir Med. 2005;4(1):41-52.
12. Hochrainer D, Hölz H, Kreher C, Scaffidi L, Spallek M, Wachtel H. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers. J Aerosol Med. 2005;18(3):273-282.